<?xml version="1.0" encoding="UTF-8"?>
<p id="p0150">Among neurodegenerative diseases, it should be mentioned that CoVs could also take part in the pathogenesis of Parkinson's disease (PD), mainly based on the observation that basal ganglia are damaged during experimental CoV infection both in rodents and primates (
 <xref rid="bb0255" ref-type="bibr">Fishman et al., 1985</xref>; 
 <xref rid="bb0365" ref-type="bibr">Kersting and Pette, 1956</xref>). However, only one human study has shown higher titers of antibodies against JHMV and HCoV-OC43 in the CSF of PD patients when compared to normal age-matched controls (
 <xref rid="bb0245" ref-type="bibr">Fazzini et al., 1992</xref>).
</p>
